Indian perspective of remdesivir: A promising COVID-19 drug

Devendra Singh; Himika Wasan; Apoorva Mathur; Yogendra Kumar Gupta

doi:10.4103/ijp.IJP_486_20

	Home	IPS	Feedback	Subscribe	Top cited articles	Login

Users Online : 4310

Announcement

» Next article

» Previous article

» Table of Contents

» Similar in PUBMED

» Search Pubmed for

» Search in Google Scholar for

» Citation Manager

» Access Statistics

» Reader Comments

» Email Alert *

» Add to My List *

* Requires registration (Free)

Article Access Statistics

Viewed	2675

Printed	59

Emailed	0

PDF Downloaded	220

Comments	[Add]

Cited by others	4

Click on image for details.

LETTER TO THE EDITOR

Year : 2020 | Volume : 52 | Issue : 3 | Page : 227-228

Indian perspective of remdesivir: A promising COVID-19 drug

Devendra Singh¹, Himika Wasan¹, Apoorva Mathur², Yogendra Kumar Gupta¹
¹ Department of Pharmacology, AIIMS, New Delhi, India
² Centre for Dental Education and Research, AIIMS, New Delhi, India

Correspondence Address:
Dr. Yogendra Kumar Gupta
Translational Health Science and Technology Institute
India

Source of Support: None, Conflict of Interest: None

Check

DOI: 10.4103/ijp.IJP_486_20

[FULL TEXT] [PDF]*

Online since 20^th July '04

Published by Wolters Kluwer - Medknow